Your browser doesn't support javascript.
loading
Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861.
Panjideh, Hossein; Niesler, Nicole; Weng, Alexander; Fuchs, Hendrik.
Affiliation
  • Panjideh H; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Augustenburger Platz 1, D-13353 Berlin, Germany.
  • Niesler N; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Augustenburger Platz 1, D-13353 Berlin, Germany.
  • Weng A; Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Straße 2+4, D-14195 Berlin, Germany.
  • Fuchs H; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Augustenburger Platz 1, D-13353 Berlin, Germany.
Toxins (Basel) ; 14(7)2022 07 13.
Article in En | MEDLINE | ID: mdl-35878216
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotoxins / Lymphoma, B-Cell / Lymphoma / Neoplasms Limits: Animals / Humans Language: En Journal: Toxins (Basel) Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotoxins / Lymphoma, B-Cell / Lymphoma / Neoplasms Limits: Animals / Humans Language: En Journal: Toxins (Basel) Year: 2022 Document type: Article Affiliation country: Country of publication: